The surrounding buzz is deafening, fuelled by incredible claims of effortless weight loss. But while Berberine, or Daru Haldi ...

Novo Nordisk's beaten-down valuation became too attractive to pass up, so I bought the stock earlier this year. Eli Lilly's ...

What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.1% in the morning session after the ...

Hims & Hers announced plans to expand its weight loss program to Canada in 2026 in connection with the availability of generic semaglutide anywhere in the world.

A recent Digiday piece revealed just how bad it’s gotten: There’s been a 717% (in truly mind-blowing words: seven hundred ...

The rise of Ozempic and weight-loss drugs is a convenient excuse for the fashion industry and retailers to cut back on plus-size clothing options.

Now Perkins, the ESPN NBA analyst, has a weight-loss suggestion for Knicks’ center and New Jersey native Karl-Anthony Towns. ...

Some online pharmacies sell semaglutide and tirzepatide that are ineffective, unsafe, or an outright scam. Here’s how to find ...

Hims & Hers, the high-flying online health company that rapidly grew from a buzzy startup selling Viagra to a ...

Discover why Novo Nordisk's current sell-off offers a strong buy opportunity. Backed by solid fundamentals, growth prospects, ...

Brandon mortgages his house and rental properties to buy a Commercial Roofing Construction Company. Follow the journey as he ...